DANIELLE BLAKE: Open Payments
NPI 1144836701 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,863 in 35 payments from 10 companies in 2025. Trend: 2023 $4,991 · 2024 $20,148 · 2025 $7,863
Speaker / faculty: $5,850Food & beverage: $1,347Travel & lodging: $666
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $6,881 |
| Janssen Biotech, Inc. | 2 | $214 |
| PFIZER INC. | 1 | $181 |
| Syndax Pharmaceuticals, Inc. | 6 | $153 |
| JAZZ PHARMACEUTICALS INC. | 2 | $144 |
| BeiGene USA, Inc. | 1 | $144 |
| Alnylam Pharmaceuticals Inc. | 2 | $60 |
| BeOne Medicines USA, Inc. | 2 | $39 |
| Kite Pharma, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: OJJAARA, BRUKINSA, RYLAZE, DARZALEX, REVUFORJ, TALVEY, AMVUTTRA, Yescarta.
Industry payments across MI — which companies pay providers there.
